Start with a free account for 12 free CME credits. Already a subscriber? Sign in.

September Hotsheet - EpiPen ,PATCH, and PEAPETT

Mel Herbert, MD MBBS FAAEM and Rob Orman, MD
00:00
07:41
Sign in or subscribe to listen

No me gusta!

The flash player was unable to start. If you have a flash blocker then try unblocking the flash content - it should be visible below.

10 years ago, an EpiPen 2 pack cost around $100 US. Now, it’s $600. What’s going on? Rob and Mel discuss.

The PATCH study found that in patients who were on antiplatelet agents and had a spontaneous cerebral haemorrhage, giving platelets increased the risk of both death and poor neurologic outcomes.

Should you give lytics in the PEA patient in whom you suspect pulmonary embolism? A recent series of 23 patients with PE and PEA demonstrated survival after getting a dose of TPA.

Congratulations to challenge coin recipient Dr. Emberlynn Liu

To view chapter written summaries, you need to subscribe.

Sign up today for full access to all episodes.

To join the conversation, you need to subscribe.

Sign up today for full access to all episodes and to join the conversation.

To download files, you need to subscribe.

Sign up today for full access to all episodes.
September Hotsheet - EpiPen, PATCH, and PEAPETT Full episode audio for MD edition 7:41 min - 6 MB - M4A